[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368243-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368243-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","an-anoikis-related-signature-predicts-prognosis-and-immunotherapy-response-in-gastrointestinal-cancers","An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers","","Gastrointestinal cancers remain highly lethal, and effective prognostic indicators are still limited. This study investigates how anoikis-related genes (ARGs) relate to outcomes and immunotherapy response in esophageal, gastric, colon, and rectal cancers. RNA-seq and clinical data were integrated, ARGs were identified, and anoikis-related patterns were defined through unsupervised clustering. A prognostic signature (Anoscore) was built and validated using survival and predictive performance analyses, with additional single-cell, tumor microenvironment, and drug-sensitivity investigations, plus experimental validation of candidate genes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/an-anoikis-related-signature-predicts-prognosis-and-immunotherapy-response-in-gastrointestinal-cancers/368243/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/an-anoikis-related-signature-predicts-prognosis-and-immunotherapy-response-in-gastrointestinal-cancers/368243.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",15,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study aim to determine about GI cancers?","Question",{"text":63,"@type":64},"The study explores the roles of anoikis-related genes in gastrointestinal cancer prognosis and how these genes may inform immunotherapy response and personalized treatment selection.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the anoikis-related patterns and prognostic signature constructed?",{"text":68,"@type":64},"Anoikis-related patterns were identified using unsupervised clustering of ARGs. A prognostic signature (Anoscore) was developed from prognostic ARGs using univariate, LASSO, and multivariate Cox regression analyses, then validated with multiple survival and performance metrics.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationships were found between Anoscore, tumor immunity, and drug sensitivity?",{"text":72,"@type":64},"Higher Anoscores were associated with worse outcomes, greater immune cell infiltration, higher immune checkpoint expression, and differential sensitivity to chemotherapies and targeted drugs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368243,1790216665,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Original Research PUBLISHED 06 February 2025 DOI 10.3389/fimmu.2025.1477913  \nOPEN ACCESS  \nEDITED BY  \nChih-Yang Wang,  \nTaipei Medical University, Taiwan  \nREVIEWED BY  \nKeren Jia,  \nPeking University, China Qing Sun,  \nPeople’s Liberation Army Navy 971 Hospital, China  \nFan Chen,  \nSun Yat-sen University Cancer Center (SYSUCC), China  \n*CORRESPONDENCE  \nYufeng Cheng  \n [qlcyf@sdu.edu.cn](qlcyf@sdu.edu.cn)[ ](qlcyf@sdu.edu.cn)Pengxiang Chen  \n [bretcpx@163.com](bretcpx@163.com)  \nRECEIVED 08 August 2024  \nACCEPTED 21 January 2025  \nPUBLISHED 06 February 2025  \nCITATION  \nLiu R, Liu Y, Huang W, Chen P and Cheng Y (2025) An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers.  \nFront. Immunol. 16:1477913 .  \ndoi: 10.3389/fimmu.2025.1477913  \nCOPYRIGHT  \n© 2025 Liu, Liu, Huang, Chen and Cheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nAn anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers  \nRuyi Liu 1,2,3,4,5, Yuchen Liu 1,2,3,4,5, Weicheng Huang 1,2,3,4,5, Pengxiang Chen 1,2,3,4,5* and Yufeng Cheng 1,2,3,4,5*  \n1 Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, China, 2Shandong Provincial Key Laboratory of Malignant Tumor Precision Treatment, Jinan, China, 3Shandong Provincial Engineering Research Center for Tumor Precision Treatment, Jinan, China, 4Cancer Institute of Shandong University, Jinan, China, 5 Neutron Medical Center, Qilu Hospital of Shandong University, Jinan, China  \nBackground: Gastrointestinal (GI) cancers have high incidence rates and mortality rates. Anoikis is a special type of cell apoptosis, and anoikis resistance has been reported to be associated with tumor malignancy. We aimed to explore the roles of anoikis-related genes (ARGs) in the GI cancer prognosis.  \nMethods: We extracted RNA sequencing and clinical data from The Cancer Genome Atlas and Gene Expression Omnibu databases for patients with esophageal cancer, gastric cancer, colon cancer and rectal cancer and identiﬁed ARGs from GeneCards and Harmonizome. Anoikis-related patterns were identiﬁed via unsupervised clustering analysis. We constructed a prognostic signature (Anoscore) based on prognostic ARGs through univariate, LASSO, and multivariate Cox regression analyses. The model was validated and evaluated using Kaplan–Meier analysis, receiver operating characteristic curves, univariate Cox regression analysis, multivariate Cox regression analysis, column charts, and calibration curves. We also performed a single-cell sequencing analysis of candidate genes via TISCH2 . A correlation analysis between the Anoscore, the tumor microenvironment and drug sensitivity was conducted in GI cancers. The expression and function of some candidate genes were validated in vitro.  \nResults: In terms of prognostic ARGs, two anoikis-related patterns, ARG clusters A and B, were identiﬁed. ARG cluster B had a worse prognosis than did ARG cluster A. Subsequently, the Anoscore was developed as an independent prognostic factor. It demonstrated the robust predictive capability for the prognosis of patients with GI cancers. Notably, patients with high Anoscores exhibited poor outcomes. In addition, we established a nomogram (Anonomogram) based on the Anoscore and clinicopathological factors of patients to predict the 3-year and 5-year survival probabilities. Moreover, patients with high Anoscores had higher levels of immune cell inﬁltration and higher immune checkpoint expression. The drug sensitivity analysis revealed that patients with hi","cbCaikuq4y1F3lb6","https://ap.wps.com/l/cbCaikuq4y1F3lb6","pdf",19595810,17,"English","# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What does the study aim to determine about GI cancers?\",\"answer\":\"The study explores the roles of anoikis-related genes in gastrointestinal cancer prognosis and how these genes may inform immunotherapy response and personalized treatment selection.\"},{\"question\":\"How were the anoikis-related patterns and prognostic signature constructed?\",\"answer\":\"Anoikis-related patterns were identified using unsupervised clustering of ARGs. A prognostic signature (Anoscore) was developed from prognostic ARGs using univariate, LASSO, and multivariate Cox regression analyses, then validated with multiple survival and performance metrics.\"},{\"question\":\"What relationships were found between Anoscore, tumor immunity, and drug sensitivity?\",\"answer\":\"Higher Anoscores were associated with worse outcomes, greater immune cell infiltration, higher immune checkpoint expression, and differential sensitivity to chemotherapies and targeted drugs.\"}]","An anoikis-related signature predicts prognosis and immunotherapy response in gastrointestinal cancers | PDF",1790175846,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/376abac2c6c4463e87d6f4ce36d72b34.webp",983,1389,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c4888c42fce72bb6b69b40e7aa574a09.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bd23767868d7b15919cf870c6f0b260.webp",981,1386,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/447d0d001b2b9597446252304746bb01.webp",980,1385]